clinical trial · NCT06701513
A Real-world Study to Evaluate the Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in France (RePhlect)
Bristol-Myers Squibb·—·recruiting·n = 350
PsoriasisDeucravacitinib
brief summary
The purpose of this study is to assess the real-world effectiveness of deucravacitinib treatment in adults diagnosed with moderate-to-severe plaque psoriasis
started
Jan 29, 2025
primary completion
Apr 30, 2028
completion
Apr 30, 2028
last updated
Apr 11, 2025
official title
Registry of Psoriasis Health Outcomes: A Longitudinal Real-world Collaboration (RePhlect) - A Real-world, Prospective, Observational Study of the Effectiveness of Deucravacitinib in Adults With Moderate-to-Severe Plaque Psoriasis in France
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol